PDL BioPharma, Inc. misses by $0.04, misses on revenue

• PDL BioPharma, Inc. (NASDAQ:PDLI): Q4 EPS of $0.39 misses by $0.04.
• Revenue of $110.14M (+28.0% Y/Y) misses by $5.08M.
• Press Release